Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates

Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $4.38 per share, beating the Zacks Consensus Estimate of$ 4.13 per share. This compares to earnings of $4.08 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6.05%. A quarter ago, it was expected that this drugmaker would post a loss of$ 11.50 per share when it actually produced a loss of $12.83, delivering a surprise of -11.57%.Over the last four quarters, the c ...